These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 550692)

  • 21. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
    Stanczyk FZ; Miyakawa I; Goebelsmann U
    Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation.
    Serup J; Bostofte E; Larsen S; Westergaard J
    Acta Obstet Gynecol Scand; 1981; 60(2):203-6. PubMed ID: 7018165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral contraceptives and ascorbic acid.
    Rivers JM
    Am J Clin Nutr; 1975 May; 28(5):550-4. PubMed ID: 1093379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid excretion in users of the injectable combined oestrogen progestogen preparation, deladroxate.
    Zaki K; Younis N; Nour H
    Egypt Popul Fam Plann Rev; 1971 Dec; 4(2):1-5. PubMed ID: 12255961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum estradiol in women ingesting combination oral contraceptive steroids.
    Mishell DR; Thorneycroft IH; Nakamura RM; Nagata Y; Stone SC
    Am J Obstet Gynecol; 1972 Dec; 114(7):923-8. PubMed ID: 4645131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy.
    Tulchinsky D; Hobel CJ; Yeager E; Marshall JR
    Am J Obstet Gynecol; 1972 Apr; 112(8):1095-100. PubMed ID: 5025870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous estrogen therapy. Endometrial response and metabolic effects.
    Holst J
    Acta Obstet Gynecol Scand Suppl; 1983; 115():1-30. PubMed ID: 6574685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The measurement of secretory endometrial protein PP14 in serum from postmenopausal women receiving unopposed estrogen or continuously combined estrogen/progestogen.
    Byrjalsen I; Riis BJ; Christiansen C
    Gynecol Endocrinol; 1989 Jun; 3(2):143-52. PubMed ID: 2816479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estriol concentrations in plasma of normal, non-pregnant women.
    Rotti K; Stevens J; Watson D; Longcope C
    Steroids; 1975 Jun; 25(6):807-16. PubMed ID: 1171542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oestrone, oestradiol-17beta and oestriol levels in human foetal plasma during gestation and at term.
    Shutt DA; Smith ID; Shearman RP
    J Endocrinol; 1974 Feb; 60(2):333-41. PubMed ID: 4815987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
    Jensen J; Christiansen C; Rødbro P
    N Engl J Med; 1985 Oct; 313(16):973-5. PubMed ID: 4047104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. II. Plasma lipids.
    Wallentin L; Larsson-Cohn U
    Acta Endocrinol (Copenh); 1977 Nov; 86(3):597-607. PubMed ID: 200045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preclinical research and development of norethisterone].
    Mcguire JL; Hahn DW; Philipps A
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of menopausal status and sequential mestranol and norethisterone on serum cholesterol, triglyceride and electrophoretic lipoprotein patterns.
    Paterson ME; Sturdee DW; Moore B; Whitehead TP
    Br J Obstet Gynaecol; 1979 Oct; 86(10):810-5. PubMed ID: 508663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial effect of oral estriol treatment in postmenopausal women.
    Englund DE; Johansson ED
    Acta Obstet Gynecol Scand; 1980; 59(5):449-51. PubMed ID: 7446012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral treatment of menopausal symptoms with natural oestrogens. Experiences with a new series of oestrogens and oestrogen-gestagen combinations.
    Borglin NE; Staland B
    Acta Obstet Gynecol Scand Suppl; 1975; 43():1-11. PubMed ID: 1060357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.